Incoming public biotech companies in 2022
Assessing supply/demand and forecasted impact on $XBI
Happy 2022, Boutique Biotech readers! 2021 was a record year for biotech IPOs. The number of recent crossover rounds suggests that 2022 could be even busier.
According to investment bank SVB Leerink, who specialize in biotech, there were 179 crossover rounds since 2020. These are private rounds done just before a company is preparing to “crossover” into…